SCHEMBL5175478

SCHEMBL5175478

CCCOC(C)Cc1ccccc1Oc1ncccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
P2RY1 P47900 2/20 0.36
ALDH1A1 P00352 2/20 0.35
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
ADRA2A P08913 2/20 0.34
ADRA2B P18089 2/20 0.34
ADRA2C P18825 2/20 0.34
HTR1A P08908 1/20 0.34
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
PDE5A O76074 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175233 0.81 ALDH1A1 (0.58) ALDH1A1ADRA2AADRA2BADRA2C
SCHEMBL5175474 0.73 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19P2RY1ALDH1A1
SCHEMBL3257799 0.72 P2RY1 (0.45) CYP1A2CYP2C9CYP2C19P2RY1ALDH1A1
SCHEMBL1936652 0.70 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1PDE5A
SCHEMBL12680868 0.70 P2RX3 (0.52) P2RY1ALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL5175471 0.70 ALDH1A1 (0.40) CYP1A2CYP2C9CYP2C19P2RY1ALDH1A1
SCHEMBL15899526 0.70 THRA (0.38) ALDH1A1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL15899527 0.69 SLC6A2 (0.38) ALDH1A1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL1340918 0.68 ALDH1A1 (0.53) CYP1A2CYP2C19ALDH1A1SLC6A2SLC6A4
SCHEMBL12681546 0.67 ALDH1A1 (0.41) CYP1A2CYP2C9CYP2C19ALDH1A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751113-A1 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS Bristol-Myers Squibb Pharma Company (US) 2007-02-14 EP disclosed
WO-2005113511-A1 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-01 WO disclosed